These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

Steward Partners Investment Advisory LLC trimmed its holdings in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report ...

Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, ...

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate ...

With a promising outlook for PTC India and Piramal Pharma, Bajaj Broking identifies key stock picks poised for over 15% ...